soul trial oral semaglutide cardiovascular outcomes soul trial results Reduces Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary From the Randomized The SOUL Study - by
Pay in 4 interest-free payments of $5.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18























